Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;145(6):280-284.e1.
doi: 10.3821/145.6.cpj280.

Prescribing gabapentin off label: Perspectives from psychiatry, pain and neurology specialists

Christine Fukada, Jillian Clare Kohler, Heather Boon, Zubin Austin, Murray Krahn

Prescribing gabapentin off label: Perspectives from psychiatry, pain and neurology specialists

Christine Fukada et al. Can Pharm J (Ott). 2012 Nov.

Abstract

Objective: The objective of the study was to explore the experiences of physicians prescribing gabapentin off label.

Methods: We used a case study approach to explore the experiences of physicians prescribing gabapentin for off-label indications. Semi-structured interviews were conducted with 10 physicians (psychiatry, pain and neurology specialists) in the Greater Toronto Area. Data were collected to the point of saturation of key themes and analyzed using interpretive content analysis.

Key findings: Key informants appeared to rely primarily on informal information from colleagues and meetings, putting into question the accuracy of their information about the potential off-label uses of gabapentin. Our findings suggest the need for more evidence-based information on off-label drug use.

Conclusion: There is a need for greater understanding of off-label prescribing practices as an important step toward improving rational prescribing and ultimately toward improving patient safety and health outcomes.

PubMed Disclaimer

References

    1. Boos J. Off label use — label off use? Ann Oncol. 2003;14:1–5. - PubMed
    1. Klein DB, Tabarrok A. Who certifies off-label? Regulation. 2004;27:60–3. Available: www.cato.org/pubs/regulation/regv27n2/v27n2-8.pdf (accessed January 29, 2005)
    1. Nightingale SL. Off-label use of prescription drugs. Am Fam Physician. 2003;68:425–7. - PubMed
    1. Gazarian M, Kelly M, McPhee JR. Off-label uses of medicines: consensus recommendations for evaluating appropriateness. Med J Aust. 2006;185:544–8. et al. - PubMed
    1. Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am Fam Physician. 2003;68:498–504. - PubMed